Revenue: Not disclosed (nil in QQ2 2024). Gross Profit: Not disclosed (nil). Operating Income: -$150,680 in QQ2 2024; QoQ improvement from -$220,190 in Q1 2024; YoY not applicable given SPAC shell status. Net Income: $303,423 in QQ2 2024; YoY -47.76% (vs Q2 2023 net income of $580,782); QoQ +37.78% (from Q1 2024 net income $220,219). EPS: $0.0475 in QQ2 2024; YoY -46.57%; QoQ +37.68%. Cash Flow from Operations: -$166,897; Free Cash Flow: -$166,899; Net cash provided by financing activities: +$572,856; Net change in cash: +$3,075; Cash at end of period: $4,200.
Balance Sheet health shows: Cash and cash equivalents $4,200; Short-term investments $35,448,136; Total assets $35,504,084; Total liabilities $8,368,003; Total stockholders’ equity $27,136,081. Current ratio 0.0129; Quick ratio 0.0129; Debt to equity 0.115; Net debt about $3.10 million. Price-to-book 2.82; Price-to-earnings 62.96 (SPAC multiples reflect lack of recurring earnings). The company carries a large investment portfolio relative to cash, which supports its ability to pursue a business combination but exposes the near term to market-driven asset value and impairment risk.